Linda S Mulkahy

Title: Innovations of Linda S. Mulkahy

Introduction

Linda S. Mulkahy is a notable inventor based in Yardley, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of methods related to erythropoietin receptor binding proteins. Her work has implications for drug design and therapeutic applications.

Latest Patents

Mulkahy holds a patent for "Methods for identifying erythropoietin receptor binding protein." This invention involves the expression and overproduction of the extracellular domain of the human erythropoietin receptor, known as EPO binding protein (EBP). The methods disclosed in her patent allow for the efficient recovery of purified EBP, which quantitatively binds EPO. The active purified protein competes with the membrane-associated EPO receptor for binding and neutralizes EPO-dependent stimulation in a cell-based proliferation assay. Additionally, the patent details the production of a fusion protein of EBP and an immunoglobulin heavy chain, termed EBP-Ig, which serves as a preformed dimerization template useful in drug design and discovery.

Career Highlights

Mulkahy's career is marked by her innovative research and development efforts at Ortho Pharmaceutical Corporation. Her work has contributed to advancements in understanding the interactions between EPO and its receptor, which is crucial for therapeutic applications in treating various medical conditions.

Collaborations

Mulkahy has collaborated with notable colleagues, including Steven A. Middleton and Dana Johnson. These partnerships have enhanced her research and contributed to the successful development of her patented technologies.

Conclusion

Linda S. Mulkahy's contributions to biotechnology through her innovative patents and collaborative efforts highlight her role as a significant inventor in her field. Her work continues to influence drug design and therapeutic strategies.